• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.

作者信息

Livornese L L, Gold M, Johnson C C, Measley R, Kaye D, Korzeniowski O, Walsh M L, Samel C, Hessen M, Levison M E

出版信息

J Antimicrob Chemother. 1993 Jan;31(1):188-91. doi: 10.1093/jac/31.1.188.

DOI:10.1093/jac/31.1.188
PMID:8444670
Abstract
摘要

相似文献

1
Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections.替考拉宁治疗革兰氏阳性菌血管内感染的临床评估
J Antimicrob Chemother. 1993 Jan;31(1):188-91. doi: 10.1093/jac/31.1.188.
2
Treatment of Peptostreptococcus micros endocarditis with teicoplanin.用替考拉宁治疗微小消化链球菌心内膜炎
Clin Infect Dis. 1995 Aug;21(2):446-7. doi: 10.1093/clinids/21.2.446.
3
Teicoplanin in the treatment of serious infection.替考拉宁治疗严重感染。
J Chemother. 2000 Nov;12 Suppl 5:26-33. doi: 10.1080/1120009x.2000.11782315.
4
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna.达巴万星作为革兰阳性菌感染性心内膜炎的初始和序贯治疗：维也纳总医院 2 年经验。
Clin Infect Dis. 2018 Aug 16;67(5):795-798. doi: 10.1093/cid/ciy279.
5
Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases.达巴万星作为静脉源革兰阳性菌血症患者的长期抑制疗法：一系列 4 例报告。
Infection. 2021 Feb;49(1):181-186. doi: 10.1007/s15010-020-01526-0. Epub 2020 Sep 23.
6
Dosage recommendations for teicoplanin.替考拉宁的剂量推荐。
J Antimicrob Chemother. 1993 Dec;32(6):792-6. doi: 10.1093/jac/32.6.792.
7
Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.链球菌、肠球菌及葡萄球菌性心内膜炎的抗生素治疗。英国抗菌化疗学会工作小组
Heart. 1998 Feb;79(2):207-10.
8
Success of teicoplanin over vancomycin in streptococcal endocarditis.
J Infect. 1994 Jan;28(1):105-7. doi: 10.1016/s0163-4453(94)94564-0.
9
Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
J Infect Dis. 1994 Nov;170(5):1344-5. doi: 10.1093/infdis/170.5.1344.
10
Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study.替考拉宁治疗肠球菌性心内膜炎：临床与微生物学研究
J Antimicrob Chemother. 1997 Sep;40(3):449-52. doi: 10.1093/jac/40.3.449.

引用本文的文献

1
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.替考拉宁：对其用于治疗革兰氏阳性菌感染的药物经济学评价
Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.
2
A risk-benefit assessment of teicoplanin in the treatment of infections.替考拉宁治疗感染的风险效益评估。
Drug Saf. 1995 Nov;13(5):317-28. doi: 10.2165/00002018-199513050-00005.
3
Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
4
Teicoplanin: 10 years of clinical experience.替考拉宁：10年临床经验
Infection. 1994 Nov-Dec;22(6):430-6. doi: 10.1007/BF01715507.
5
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.替考拉宁：对其抗菌活性、药代动力学特性及治疗效果的重新评估
Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008.